Akèy › VIH
Etid klinik pou VIH ap rekrite nan Etazini
137 etid pou VIH ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Washington, DC22 etid
- New York City, NY18 etid
- Houston, TX17 etid
- Miami, FL17 etid
- Baltimore, MD16 etid
- San Francisco, CA15 etid
- Chicago, IL14 etid
- Atlanta, GA14 etid
- Philadelphia, PA11 etid
- Boston, MA11 etid
- San Diego, CA10 etid
- Los Angeles, CA9 etid
- Seattle, WA8 etid
- Columbus, OH7 etid
- Birmingham, AL7 etid
- Dallas, TX7 etid
- Orlando, FL7 etid
- New Haven, CT7 etid
- Durham, NC6 etid
- West Palm Beach, FL6 etid
- Winston-Salem, NC5 etid
- New Orleans, LA5 etid
- Salt Lake City, UT5 etid
- Aurora, CO5 etid
- The Bronx, NY5 etid
- Tampa, FL5 etid
- Port Saint Lucie, FL5 etid
- Kansas City, MO5 etid
- Newark, NJ5 etid
- Las Vegas, NV4 etid
- Nashville, TN4 etid
- Jacksonville, FL4 etid
- St. Louis, MO4 etid
- Cincinnati, OH4 etid
- Greensboro, NC4 etid
- Burbank, CA4 etid
- Austin, TX3 etid
- Minneapolis, MN3 etid
- Memphis, TN3 etid
- Miami Gardens, FL3 etid
Pa eta
- Alabama9 etid
- Colorado7 etid
- Connecticut8 etid
- Distrik Columbia9 etid
- Florid26 etid
- Georgia14 etid
- Illinois14 etid
- Kalifòni33 etid
- Kentucky3 etid
- Lwizyàn6 etid
- Maryland29 etid
- Massachusetts12 etid
- Michigan4 etid
- Minnesota3 etid
- Missouri8 etid
- Nevada4 etid
- New Jersey6 etid
- New York22 etid
- North Carolina13 etid
- Ohio10 etid
- Pennsylvania11 etid
- Tennessee7 etid
- Texas23 etid
- Utah5 etid
- Virginia4 etid
- Washington8 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06883097Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT00006518A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07650916Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT00039689Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT03300830Viral Load in Blood and Lymph Tissues in People Living With HIV
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT00001316HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
Ap rekriteFaz 1
Laj 50 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06513819Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Sep 22, 2026 · NCT00029445ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06274632Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 12 a 120 · Tout sèks · Mizajou Sep 22, 2026 · NCT05470491Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Sep 22, 2026 · NCT05419024El Camino HIV Prevention and Care Study
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 22, 2026 · NCT07834853The TAIL-PrEP Study
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06868641A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities
Ap rekriteVolontè an sante akeyi
Laj 15 a 26 · Tout sèks · Mizajou Sep 21, 2026 · NCT06428643A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07266831Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Sep 18, 2026 · NCT06665646Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples
Ap rekriteVolontè an sante akeyi
Laj 18 a 55 · Gason · Mizajou Sep 17, 2026 · NCT06307977Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
Ap rekriteFaz 1
Laj 18 a 99 · Tout sèks · Mizajou Sep 17, 2026 · NCT04902443A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
Ap rekrite
Laj 50 a 75 · Tout sèks · Mizajou Sep 16, 2026 · NCT06586619Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07473778Observational Pharmaco-Epidemiology Research & Analysis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 0 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT03813862PRIDE III Prison Interventions and HIV Prevention Collaboration
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06962033Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Ap rekriteFaz 1/2
48 Hours · Tout sèks · Mizajou Sep 9, 2026 · NCT02140255Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People
Ap rekriteVolontè an sante akeyi
Laj 15 a 30 · Tout sèks · Mizajou Sep 9, 2026 · NCT05816083SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT00187512Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.